Fake research papers fuelling AI algorithms, turning fiction into fact
HQ Team April 21, 2026: When a Swedish researcher named Almira Osmanovic Thunström invented a disease called “bixonimania” in early 2024, she expected.
Health
Opinion
Research
Health
Research
Governance through waiting rooms; how the state uses time as a tool of control
Healthquill Team and Bhartijay April 21, 2026: In 2011, sociologist Javier Auyero spent six months sitting in a welfare office in Buenos Aires..
Health
Research
WSU study reveals how endometriosis rewires the brain to amplify chronic pain
Swati Sri A Washington State University (WSU) study has uncovered the biological mechanism behind one of the most frustrating aspects of endometriosis: why.
Health
Newly recognized Type-5 diabetes may be affecting 25 million people worldwide
Swati Sri April 15, 2026: The International Diabetes Federation (IDF) has officially recognized a distinct fifth type of diabetes known as Type 5.
Drugs
Health
Pharma
Novartis AG to acquire Exellergy for $2 billion, expand allergy portfolio
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Uncategorized
Genetic study finds how Kenya’s Turkana survive with almost no water
HQ Staff writer March 26, 2026: Deep in the sun-scorched lands of northern Kenya, where temperatures soar and water sources vanish for months.
Drugs
Health
Pharma
Merck to buy Terns for $6.7 billion as Keytruda drug patent loss looms
Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a.
Drugs
Health
Pharma
Novo, United’s trial drug cuts sugar levels by 2.16%, weight loss of 9.8%
HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing.
Drugs
Medical
Pharma
Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy
HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals.
Drugs
Medical
Pharma
Gilead Sciences to acquire US-based Ouro Medicines for up to $2 billion
Gilead Sciences, Inc., will acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases, for.